How should anticoagulation be managed in a patient with a recent cerebrovascular accident (stroke) and bilateral pulmonary embolism?

Management of Anticoagulation in CVA with Bilateral PE

In a patient with recent stroke and bilateral PE, initiate anticoagulation with unfractionated heparin (UFH) without bolus after confirming hemorrhagic transformation status on neuroimaging, with timing determined by stroke type and severity—or consider IVC filter placement with mechanical thrombectomy if the PE is hemodynamically significant and the stroke involves hemorrhagic transformation.

Risk Stratification Framework

The management hinges on two critical determinations:

1. Stroke type: Ischemic (AIS) vs. hemorrhagic (ICH)
2. PE severity: High-risk (hemodynamically unstable) vs. intermediate/low-risk (stable)

For Ischemic Stroke (AIS) with PE

Assess for Hemorrhagic Transformation First

Obtain urgent neuroimaging to determine if hemorrhagic transformation has occurred 1.

If NO Hemorrhagic Transformation:

Initiate anticoagulation based on stroke severity 1:

• TIA: Start within 1-3 days
• Mild stroke: Start ≥3 days after symptom onset
• Moderate stroke: Start ≥6-8 days after symptom onset
• Severe stroke: Start ≥12-14 days after symptom onset

For the PE component 2:

• If hemodynamically stable: Use LMWH or fondaparinux (preferred over UFH) 2
• Transition to NOAC (apixaban, dabigatran, edoxaban, or rivaroxaban) when appropriate 2
• If hemodynamically unstable (high-risk PE): This creates a critical dilemma—systemic thrombolysis is contraindicated due to recent stroke. Consider mechanical thrombectomy with IVC filter placement 3, 4

If Hemorrhagic Transformation Present:

This converts the management to the ICH protocol below.

For Hemorrhagic Stroke (ICH) with PE

High-Risk PE (Hemodynamically Unstable):

Mechanical intervention is the safest approach 3, 4, 5:

• Pulmonary artery thrombectomy (catheter-directed, lytic-free) combined with IVC filter placement 3
• This allows an anticoagulation-free period for hematoma stabilization
• Avoids systemic thrombolysis which is absolutely contraindicated 2

Intermediate/Low-Risk PE (Hemodynamically Stable):

Delay therapeutic anticoagulation by 1-2 weeks 1:

• Place retrievable IVC filter as bridging therapy 1, 2
• Decision based on:
  • Hematoma stability on serial CT imaging (most critical factor)
  • Hemorrhage location (lobar vs. deep cerebral)
  • Patient age
  • Normal INR levels

When to initiate anticoagulation 1, 6, 5, 7:

• Confirm radiological hematoma stability on repeat imaging
• Start with UFH infusion without bolus under close neurological monitoring 6, 5
• Titrate carefully with serial aPTT monitoring
• Perform frequent neurological assessments and repeat CT imaging to detect hemorrhage progression
• Transition to therapeutic-dose LMWH or NOAC only after confirmed stability 6, 7

Critical Pitfalls to Avoid

1. Do NOT use systemic thrombolysis in any patient with recent stroke (ischemic or hemorrhagic) and concurrent PE 2, 4
2. Do NOT give UFH bolus when initiating anticoagulation in hemorrhagic stroke—use infusion only 6, 5
3. Do NOT use NOACs in severe renal impairment, pregnancy, or antiphospholipid syndrome 2
4. Do NOT delay imaging to assess hemorrhagic transformation—this is the pivotal decision point 1
5. Do NOT routinely place IVC filters without clear indication (absolute contraindication to anticoagulation or recurrent PE despite adequate anticoagulation) 2

Evidence Quality Considerations

The 2025 guideline 1 provides the most recent stroke-specific VTE management framework, emphasizing individualized timing based on hemorrhagic transformation and stroke severity. The 2019 ESC PE guidelines 2 remain the gold standard for PE management but don't specifically address concurrent stroke. Recent case series 3, 4, 5 consistently demonstrate that mechanical thrombectomy with IVC filter placement is the safest approach for high-risk PE when anticoagulation is contraindicated, with 100% survival and no bleeding complications in reported cases 3.

The literature review by 8 found that when both conditions present simultaneously, intravenous anticoagulation was most common (70.5%), but outcomes were mixed with 41% having poor outcomes. This underscores the importance of mechanical intervention for high-risk PE rather than relying solely on anticoagulation in this complex scenario.

1, 2, 3, 4, 6, 5, 7